跳至主要内容
临床试验/NCT03622450
NCT03622450已完成2 期

The Effect of Colistin Inhalation on the Clinical Outcome of Patients With Ventilator Associated Pneumonia

Nourhan Hassan Osama Thuraya Mohamed0 个研究点目标入组 40 人开始时间: 2016年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
主要终点
Assessment of Ventilatory status

研究概览

简要总结

The study has been conducted to measure the clinical outcome of early intervention with colistin inhalation in patients with ventilator associated pneumonia suspected to have multidrug resistant gram -ve bacteria

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years
  • Patients presenting with signs of infection 48 hours of intubation

排除标准

  • Patients with documented bronchiectasis
  • Cystic fibrosis Known allergy to polymyxin. Patients presenting with chest infection or signs of infection before intubation.
  • Patients with creatinine clearance less than 30ml/min.

研究组 & 干预措施

Medication arm

Experimental

Colistin to be given as 2 millions three times daily in the inhalation form from 5 to 7 days in addition to another antipseudomonal antibiotic according to infectious disease society of antimicrobials (IDSA) guidelines from day 1 of incidence of ventilator associated pneumonia

干预措施: Colistin (Drug)

Control arm

Active Comparator

Patients receive antipseudomonal antibiotics IV as carbapenem and quinolone or aminoglycoside according to IDSA guidelines from day 1 of incidence of Ventilator associated pneumonia carbapenem as 1g three times daily + tavanic 750mg once daily or ciprofloxacin 500mg twice daily or aminoglycoside according to renal function

干预措施: Carbapenem + Aminoglycoside/ Quinolone (Drug)

结局指标

主要结局

Assessment of Ventilatory status

时间窗: 7 to 10 days

Pf ratio measurement

次要结局

  • Days of mechanical ventilation(35 Days)
  • Time till the occurence of sepsis(35 Days)
  • Mortality as an outcome of long stand untreatable ventilator associated pneumonia(35 days)
  • Length of stay in the icu(35 days)

研究者

发起方
Nourhan Hassan Osama Thuraya Mohamed
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Nourhan Hassan Osama Thuraya Mohamed

Clinical pharmacist

Ain Shams University

相似试验